These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7110144)

  • 1. Effect of monoclonal anti-neuraminidase antibodies on the kinetic behavior of influenza virus neuraminidase.
    Mountford CE; Grossman G; Holmes KT; O'Sullivan WJ; Hampson AW; Raison RL; Webster R
    Mol Immunol; 1982 Jun; 19(6):811-6. PubMed ID: 7110144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic and biological characterization of influenza virus neuraminidase (N2) with monoclonal antibodies.
    Webster RG; Brown LE; Laver WG
    Virology; 1984 May; 135(1):30-42. PubMed ID: 6203218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-neuraminidase antibodies: which substrate should be used to test their effect on influenza virus neuraminidase.
    Mountford CE; Holmes KT; Hampson AW
    Biochem Biophys Res Commun; 1981 Nov; 103(2):469-74. PubMed ID: 6977358
    [No Abstract]   [Full Text] [Related]  

  • 4. Catalytic properties of the A/H3N2 influenza neuraminidases: influence of antigenic variations.
    Deshairs C; Kessler N; Aymard M; Quash GA
    J Gen Virol; 1986 Mar; 67 ( Pt 3)():409-18. PubMed ID: 3950578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of two anti-neuraminidase monoclonal antibodies by complement activation.
    Holmes KT; Hampson AW; Raison RL; Webster RG; O'Sullivan WJ; Mountford CE
    Eur J Immunol; 1982 Jun; 12(6):523-6. PubMed ID: 7117362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A topographic map of the enzyme active center and antigenic sites on the neuraminidase of influenza virus A/Tokyo/3/67 (H2N2).
    Jackson DC; Webster RG
    Virology; 1982 Nov; 123(1):69-77. PubMed ID: 6183827
    [No Abstract]   [Full Text] [Related]  

  • 7. Analysis of the binding of the Fab fragment of monoclonal antibody NC10 to influenza virus N9 neuraminidase from tern and whale using the BIAcore biosensor: effect of immobilization level and flow rate on kinetic analysis.
    Kortt AA; Nice E; Gruen LC
    Anal Biochem; 1999 Aug; 273(1):133-41. PubMed ID: 10452809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The equilibrium constant for the interaction between a monoclonal Fab fragment and an influenza virus neuraminidase.
    Jackson DC; Howlett GJ; Nestorowicz A; Webster RG
    J Immunol; 1983 Mar; 130(3):1313-6. PubMed ID: 6822736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystalline monoclonal fab fragment with specificity towards an influenza virus neuraminidase.
    Colman PM; Gough KH; Lilley GG; Blagrove RJ; Webster RG; Laver WG
    J Mol Biol; 1981 Nov; 152(3):609-14. PubMed ID: 7328664
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuraminidase-inhibition assay for the identification of influenza A virus neuraminidase subtype or neuraminidase antibody specificity.
    Pedersen JC
    Methods Mol Biol; 2008; 436():67-75. PubMed ID: 18370042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Location of antigenic sites on the three-dimensional structure of the influenza N2 virus neuraminidase.
    Air GM; Els MC; Brown LE; Laver WG; Webster RG
    Virology; 1985 Sep; 145(2):237-48. PubMed ID: 2411049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of influenza A virus neuraminidase using lectin test and monoclonal antibodies.
    Varecková E; Lyubovtseva OV; Russ G; Styk B; Zakstelskaya LYa ; Yakhno MA
    Acta Virol; 1986 Jul; 30(4):281-8. PubMed ID: 2876609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The complete neuraminidase of influenza A/PR8/34 (H0N1) is not detectable in its recombinant virus.
    Arora DJ; Hill-Schubert J
    Can J Microbiol; 1980 Nov; 26(11):1369-73. PubMed ID: 7214226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Qualitative and quantitative analyses of virtually all subtypes of influenza A and B viral neuraminidases using antibodies targeting the universally conserved sequences.
    Gravel C; Li C; Wang J; Hashem AM; Jaentschke B; Xu KW; Lorbetskie B; Gingras G; Aubin Y; Van Domselaar G; Girard M; He R; Li X
    Vaccine; 2010 Aug; 28(36):5774-84. PubMed ID: 20621113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antigenic specificity of the neuraminidases of epidemic strains of influenza A/H3N2 viruses circulating in the USSR 1983-1985].
    Liubovtseva OV; Iakhno MA; Zakstel'skaia LIa
    Vopr Virusol; 1987; 32(3):283-5. PubMed ID: 2445104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic structure and variation in an influenza virus N9 neuraminidase.
    Webster RG; Air GM; Metzger DW; Colman PM; Varghese JN; Baker AT; Laver WG
    J Virol; 1987 Sep; 61(9):2910-6. PubMed ID: 3612957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection and analysis of antigenic variants of the neuraminidase of N2 influenza viruses with monoclonal antibodies.
    Webster RG; Hinshaw VS; Laver WG
    Virology; 1982 Feb; 117(1):93-104. PubMed ID: 7064355
    [No Abstract]   [Full Text] [Related]  

  • 18. Influenza virus neuraminidase with hemagglutinin activity.
    Laver WG; Colman PM; Webster RG; Hinshaw VS; Air GM
    Virology; 1984 Sep; 137(2):314-23. PubMed ID: 6485252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuraminidase-inhibition assay for the identification of influenza A virus neuraminidase virus subtype or neuraminidase antibody specificity.
    Pedersen JC
    Methods Mol Biol; 2014; 1161():27-36. PubMed ID: 24899417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution to the standardization of influenza neuraminidase inhibition tests, based on enzyme- antienzyme kinetic studies.
    Siekmann U; Schoop HJ; Kuwert E
    Dev Biol Stand; 1975; 28():324-35. PubMed ID: 1126576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.